List of Molecular Insight Pharmaceuticals, Inc. patents

Patents where

Current Assignee

Name

‌

Molecular Insight Pharmaceuticals, Inc.

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 9956305 Organ protection in PSMA-targeted radionuclide therapy of prostate cancer	Patent 9956305 was granted and assigned to Molecular Insight Pharmaceuticals, Inc. on May, 2018 by the United States Patent and Trademark Office.	‌ Molecular Insight Pharmaceuticals, Inc.	‌ Molecular Insight Pharmaceuticals, Inc.	United States Patent and Trademark Office	9956305	May 1, 2018
‌ US Patent 9687572 PSMA-targeted dendrimers	Patent 9687572 was granted and assigned to Molecular Insight Pharmaceuticals, Inc. on June, 2017 by the United States Patent and Trademark Office.		‌ Molecular Insight Pharmaceuticals, Inc.	United States Patent and Trademark Office	9687572	June 27, 2017
‌ US Patent 8962799 Technetium—and rhenium-bis(heteroaryl) complexes and methods of use thereof	Patent 8962799 was granted and assigned to Molecular Insight Pharmaceuticals, Inc. on February, 2015 by the United States Patent and Trademark Office.	‌ Molecular Insight Pharmaceuticals, Inc.	‌ Molecular Insight Pharmaceuticals, Inc.	United States Patent and Trademark Office	8962799	February 24, 2015
‌ US Patent 9433594 Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof	Patent 9433594 was granted and assigned to Molecular Insight Pharmaceuticals, Inc. on September, 2016 by the United States Patent and Trademark Office.	‌ Molecular Insight Pharmaceuticals, Inc.	‌ Molecular Insight Pharmaceuticals, Inc.	United States Patent and Trademark Office	9433594	September 6, 2016
‌ US Patent 7314609 Stereoisomers of fatty acid analogs for diagnostic imaging	Patent 7314609 was granted and assigned to Molecular Insight Pharmaceuticals, Inc. on January, 2008 by the United States Patent and Trademark Office.		‌ Molecular Insight Pharmaceuticals, Inc.	United States Patent and Trademark Office	7314609	January 1, 2008
‌ US Patent 8211402 CA-IX specific radiopharmaceuticals for the treatment and imaging of cancer	Patent 8211402 was granted and assigned to Molecular Insight Pharmaceuticals, Inc. on July, 2012 by the United States Patent and Trademark Office.		‌ Molecular Insight Pharmaceuticals, Inc.	United States Patent and Trademark Office	8211402	July 3, 2012
‌ US Patent 7556794 Pendant fatty acid imaging agents	Patent 7556794 was granted and assigned to Molecular Insight Pharmaceuticals, Inc. on July, 2009 by the United States Patent and Trademark Office.		‌ Molecular Insight Pharmaceuticals, Inc.	United States Patent and Trademark Office	7556794	July 7, 2009
‌ US Patent 7179444 Pendant fatty acid imaging agents	Patent 7179444 was granted and assigned to Molecular Insight Pharmaceuticals, Inc. on February, 2007 by the United States Patent and Trademark Office.		‌ Molecular Insight Pharmaceuticals, Inc.	United States Patent and Trademark Office	7179444	February 20, 2007
‌ US Patent 8926944 Radiolabeled prostate specific membrane antigen inhibitors	Patent 8926944 was granted and assigned to Molecular Insight Pharmaceuticals, Inc. on January, 2015 by the United States Patent and Trademark Office.		‌ Molecular Insight Pharmaceuticals, Inc.	United States Patent and Trademark Office	8926944	January 6, 2015
‌ US Patent 9120837 Metal complexes of poly(carboxyl)amine-containing ligands having an affinity for carbonic anhydrase IX	Patent 9120837 was granted and assigned to Molecular Insight Pharmaceuticals, Inc. on September, 2015 by the United States Patent and Trademark Office.	‌ Molecular Insight Pharmaceuticals, Inc.	‌ Molecular Insight Pharmaceuticals, Inc.	United States Patent and Trademark Office	9120837	September 1, 2015
‌ US Patent 9309193 Heterodimers of glutamic acid	Patent 9309193 was granted and assigned to Molecular Insight Pharmaceuticals, Inc. on April, 2016 by the United States Patent and Trademark Office.		‌ Molecular Insight Pharmaceuticals, Inc.	United States Patent and Trademark Office	9309193	April 12, 2016
‌ US Patent 8211401 Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof for inhibiting PSMA	Patent 8211401 was granted and assigned to Molecular Insight Pharmaceuticals, Inc. on July, 2012 by the United States Patent and Trademark Office.		‌ Molecular Insight Pharmaceuticals, Inc.	United States Patent and Trademark Office	8211401	July 3, 2012
‌ US Patent 11279784 Preparations of meta-iodobenzylguanidine and precursors thereof	Patent 11279784 was granted and assigned to Molecular Insight Pharmaceuticals, Inc. on March, 2022 by the United States Patent and Trademark Office.	‌ Molecular Insight Pharmaceuticals, Inc.	‌ Molecular Insight Pharmaceuticals, Inc.	United States Patent and Trademark Office	11279784	March 22, 2022
‌ US Patent 9422251 Metal complexes of poly(carboxyl)amine-containing ligands having an affinity for carbonic anhydrase IX	Patent 9422251 was granted and assigned to Molecular Insight Pharmaceuticals, Inc. on August, 2016 by the United States Patent and Trademark Office.	‌ Molecular Insight Pharmaceuticals, Inc.	‌ Molecular Insight Pharmaceuticals, Inc.	United States Patent and Trademark Office	9422251	August 23, 2016
‌ US Patent 9447121 Triazine based radiopharmaceuticals and radioimaging agents	Patent 9447121 was granted and assigned to Molecular Insight Pharmaceuticals, Inc. on September, 2016 by the United States Patent and Trademark Office.	‌ Molecular Insight Pharmaceuticals, Inc.	‌ Molecular Insight Pharmaceuticals, Inc.	United States Patent and Trademark Office	9447121	September 20, 2016
‌ US Patent 10898598 Triazine based radiopharmaceuticals and radioimaging agents	Patent 10898598 was granted and assigned to Molecular Insight Pharmaceuticals, Inc. on January, 2021 by the United States Patent and Trademark Office.	‌ Molecular Insight Pharmaceuticals, Inc.	‌ Molecular Insight Pharmaceuticals, Inc.	United States Patent and Trademark Office	10898598	January 26, 2021
‌ US Patent 9388144 Radiolabeled prostate specific membrane antigen inhibitors	Patent 9388144 was granted and assigned to Molecular Insight Pharmaceuticals, Inc. on July, 2016 by the United States Patent and Trademark Office.	‌ Molecular Insight Pharmaceuticals, Inc.	‌ Molecular Insight Pharmaceuticals, Inc.	United States Patent and Trademark Office	9388144	July 12, 2016
‌ US Patent 8487129 Heterodimers of glutamic acid	Patent 8487129 was granted and assigned to Molecular Insight Pharmaceuticals, Inc. on July, 2013 by the United States Patent and Trademark Office.		‌ Molecular Insight Pharmaceuticals, Inc.	United States Patent and Trademark Office	8487129	July 16, 2013
‌ US Patent 10201624 Triazine based radiopharmaceuticals and radioimaging agents	Patent 10201624 was granted and assigned to Molecular Insight Pharmaceuticals, Inc. on February, 2019 by the United States Patent and Trademark Office.	‌ Molecular Insight Pharmaceuticals, Inc.	‌ Molecular Insight Pharmaceuticals, Inc.	United States Patent and Trademark Office	10201624	February 12, 2019
‌ US Patent 10131627 Heterodimers of glutamic acid	Patent 10131627 was granted and assigned to Molecular Insight Pharmaceuticals, Inc. on November, 2018 by the United States Patent and Trademark Office.	‌ Molecular Insight Pharmaceuticals, Inc.	‌ Molecular Insight Pharmaceuticals, Inc.	United States Patent and Trademark Office	10131627	November 20, 2018
‌ US Patent 11167049 Organ protection in PSMA-targeted radionuclide therapy of prostate cancer	Patent 11167049 was granted and assigned to Molecular Insight Pharmaceuticals, Inc. on November, 2021 by the United States Patent and Trademark Office.	‌ Molecular Insight Pharmaceuticals, Inc.	‌ Molecular Insight Pharmaceuticals, Inc.	United States Patent and Trademark Office	11167049	November 9, 2021
‌ US Patent 8840865 Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof	Patent 8840865 was granted and assigned to Molecular Insight Pharmaceuticals, Inc. on September, 2014 by the United States Patent and Trademark Office.	‌ Molecular Insight Pharmaceuticals, Inc.	‌ Molecular Insight Pharmaceuticals, Inc.	United States Patent and Trademark Office	8840865	September 23, 2014
‌ US Patent 8685369 Technetium- and rhenium-bis (heteroaryl) complexes, and methods of use thereof	Patent 8685369 was granted and assigned to Molecular Insight Pharmaceuticals, Inc. on April, 2014 by the United States Patent and Trademark Office.		‌ Molecular Insight Pharmaceuticals, Inc.	United States Patent and Trademark Office	8685369	April 1, 2014
‌ US Patent 7875258 Technetium-dipyridine complexes, and methods of use thereof	Patent 7875258 was granted and assigned to Molecular Insight Pharmaceuticals, Inc. on January, 2011 by the United States Patent and Trademark Office.		‌ Molecular Insight Pharmaceuticals, Inc.	United States Patent and Trademark Office	7875258	January 25, 2011
‌ US Patent 8058449 Heterodimers of glutamic acid	Patent 8058449 was granted and assigned to Molecular Insight Pharmaceuticals, Inc. on November, 2011 by the United States Patent and Trademark Office.		‌ Molecular Insight Pharmaceuticals, Inc.	United States Patent and Trademark Office	8058449	November 15, 2011

Results per page:

41 results

0 selected

41 results

0 selected